Plasma profile of microRNA after supplementation with high doses of vitamin D 3 for 12months

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Jorde, Rolf ^a,b   Svartberg, Johan ^a,b   Joakimsen, Ragnar Martin ^a,b   Coucheron, Dag H ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

microRNA; Randomized clinical trial; Vitamin D

Indexed keywords

COLECALCIFEROL; MICRORNA; PARATHYROID HORMONE; PLACEBO;

ARTICLE; BLOOD; CLINICAL TRIAL; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; PILOT STUDY; TIME;

CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICRORNAS; PARATHYROID HORMONE; PILOT PROJECTS; PLACEBOS; TIME FACTORS;

EID: 84861017541     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-245     Document Type: Article

References (37)

1. RNA maps reveals new RNA classes and a possible function for persvasive transcription. Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, Stadler PF, Hertel J, Hackermüller J, Hofacker IL, Bell I, Cheung E, Drenkow J, Dumais E, Patel S, Helt G, Ganesh M, Ghosh S, Piccolboni A, Sementchenko V, Tammana H, Gingeras TR, Science 2007 316 1484 1488 10.1126/science.1138341 17510325 (Pubitemid 46906616)
2. Non-coding RNAs: regulators of disease. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS, J Pathol 2010 220 126 139 10.1002/path.2638 19882673
3. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Lee RC, Feinbaum RL, Ambros V, Cell 1993 75 843 854 10.1016/0092-8674(93)90529-Y 8252621 (Pubitemid 24014542)
4. miRBase: integrating microRNA annotation and deep-sequencing data. Kozomara A, Griffiths-Jones S, Nucleic Acids Res 2011 39 152 D157 10.1093/nar/gkq1027 21037258
5. Functional aspects of animal microRNAs. Williams AE, Cell Mol Life Sci 2008 65 545 562 10.1007/s00018-007-7355-9 17965831 (Pubitemid 351297689)
6. MicroRNA-373 induces expression of genes with complementary promoter sequences. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R, Proc Natl Acad Sci USA 2008 105 1608 1613 10.1073/pnas.0707594105 18227514 (Pubitemid 351346562)
7. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Filipowicz W, Bhattacharyya SN, Sonenberg N, Nat Rev Genet 2008 9 102 114 18197166
8. Most mammalian mRNAs are conserved targets of microRNAs. Friedman RC, Farh KK, Burge CB, Bartel DP, Genome Res 2009 19 92 105 18955434
9. Identification of tissue-specific microRNAs from mouse. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T, Curr Biol 2002 12 735 739 10.1016/S0960-9822(02)00809-6 12007417 (Pubitemid 34455427)
10. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM, Cell 2003 113 25 36 10.1016/S0092-8674(03)00231-9 12679032 (Pubitemid 36411957)
11. MicroRNAs and endocrine biology. Cuellar T, McManus MT, J Endocrinol 2005 187 327 332 10.1677/joe.1.06426 16423811 (Pubitemid 43020253)
12. A pancreatic islet-specific microRNA regulates insulin secretion. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P, Stoffel M, Nature 2004 432 226 230 10.1038/nature03076 15538371 (Pubitemid 39545853)
13. MicroRNAs in CNS disorders. Kocerha J, Kauppinen S, Wahlestedt C, Neuromolecular Med 2009 11 162 172 10.1007/s12017-009-8066-1 19536656
14. MicroRNAs: regulating a change of heart. Barringhaus KG, Zamore PD, Circulation 2009 119 2217 2224 10.1161/CIRCULATIONAHA.107.715839 19398677
15. Cellular microRNA and P bodies modulate host-HIV-1 interactions. Nathans R, Chu CY, Serquina AK, Lu CC, Cao H, Rana TM, Mol Cell 2009 34 696 709 10.1016/j.molcel.2009.06.003 19560422
16. MicroRNAs and cancer: an overview. Medina PP, Slack FJ, Cell Cycle 2008 7 2485 2492 10.4161/cc.7.16.6453 18719380
17. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY, Cell Res 2008 18 997 1006 10.1038/cr.2008.282 18766170
18. Circulating microRNAs as stable blood-based markers for cancer detection. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M, Proc Natl Acad Sci USA 2008 105 10513 10518 10.1073/pnas.0804549105 18663219
19. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS, Harris AL, Br J Haematol 2008 141 672 675 10.1111/j.1365-2141.2008.07077.x 18318758 (Pubitemid 351667616)
20. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Stanczyk J, Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE, Detmar M, Gay S, Kyburz D, Arthritis Rheum 2008 58 1001 1009 10.1002/art.23386 18383392 (Pubitemid 351564001)
21. Origins and Mechanisms of miRNAs and siRNAs. Carthew RW, Sontheimer EJ, Cell 2009 136 642 655 10.1016/j.cell.2009.01.035 19239886
22. Overview of general physiologic features and functions of vitamin D. DeLuca HF, Am J Clin Nutr 2004 80 6 Suppl 1689S 1696S 15585789
23. Structure-function relationships in the vitamin D endocrine system. Bouillon R, Okamura WH, Norman AW, Endocr Rev 1995 16 200 257 7781594
24. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Autier P, Gandini S, Arch Intern Med 2007 167 1730 1737 10.1001/archinte.167.16.1730 17846391 (Pubitemid 47403059)
25. The role of vitamin D in cancer prevention. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, Holick MF, Am J Public Health 2006 96 252 261 10.2105/AJPH.2004.045260 16380576 (Pubitemid 43167123)
26. Vitamin D deficiency and risk of cardiovascular disease. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS, Circulation 2008 117 503 511 10.1161/CIRCULATIONAHA.107.706127 18180395
27. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Cantorna MT, Zhu Y, Froicu M, Wittke A, Am J Clin Nutr 2004 80 1717S 1720S 15585793
28. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Mattila C, Knekt P, Männistö S, Rissanen H, Laaksonen MA, Montonen J, Reunanen A, Diab Care 2007 30 2569 2570 10.2337/dc07-0292 (Pubitemid 47547796)
29. Noncalcemic actions of vitamin D receptor ligands. Nagpal S, Na S, Rathnachalam R, Endocr Rev 2005 26 662 687 10.1210/er.2004-0002 15798098 (Pubitemid 41127276)
30. A kinetic overview of the receptors involved in 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 signaling: a systems biology approach. Holmén J, Jansson A, Larsson D, Crit Rev Eukaryot Gene Expr 2009 19 181 196 10.1615/CritRevEukarGeneExpr.v19.i3.20 19883364
31. Effects of 1,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Wang WL, Chatterjee N, Chittur SV, Welsh J, Tenniswood MP, Mol Cancer 2011 10 58 10.1186/1476-4598-10-58 21592394
32. Global maternal early pregnancy peripheral blood mRNA and miRNA expression profiles according to plasma 25-hydroxyvitamin D concentrations. Enquobahrie DA, Williams MA, Qiu C, Siscovick DS, Sorensen TK, J Matern Fetal Neonatal Med 2011 24 1002 1012 10.3109/14767058.2010.538454 21219104
33. Protection against cellular stress by 25-hydroxyvitamin D3 in breast epithelial cells. Peng X, Vaishnav A, Murillo G, Alimirah F, Torres KE, Mehta RG, J Cell Biochem 2010 110 1324 1333 10.1002/jcb.22646 20564226
34. Analysis of circulating microRNA: preanalytical and analytical challenges. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A, Clin Chem 2011 57 833 840 10.1373/clinchem.2010.157198 21487102
35. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. Chen Y, Gelfond JA, McManus LM, Shireman PK, BMC Genomics 2009 10 407 10.1186/1471-2164-10-407 19715577
36. Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs. Jensen SG, Lamy P, Rasmussen MH, Ostenfeld MS, Dyrskjøt L, Orntoft TF, Andersen CL, BMC Genomics 2011 12 435 10.1186/1471-2164-12-435 21867561
37. Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Sneve M, Figenschau Y, Jorde R, Eur J Endocrinol 2008 159 675 684 10.1530/EJE-08-0339 19056900